# DreaMed Diabetes, Ltd.

- Location (FDA's records): Petah Tikva, IL
- FDA decisions: 6 (2018–2026): 5 510(k) clearances and 1 De Novo grant
- Product codes: QCC (5), QRX (1)
- Predicates its devices cite: 5 (4 its own); citations of its devices by later devices: 5 (4 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Dexcom, Inc.: 1 (https://510kreport.com/company/dexcom)

## Firms that cite its devices most
- Insulet Corporation: 1 (https://510kreport.com/company/insulet)

## Its most-cited devices
- K201476: DreaMed Advisor Pro (2020), cited by 2
- DEN170043: DreaMed Advisor Pro (2018), cited by 1
- K191370: DreaMed Advisor Pro (2019), cited by 1
- K210561: Advisor Pro Platform (2021), cited by 1

## Recent decisions
- K260062: MODI System (Sep 8, 2026)
- K232722: endo.digital Platform (Oct 3, 2023)
- K210561: Advisor Pro Platform (Sep 28, 2021)
- K201476: DreaMed Advisor Pro (Aug 28, 2020)
- K191370: DreaMed Advisor Pro (Jul 18, 2019)
- DEN170043: DreaMed Advisor Pro (Jun 12, 2018)

Source page: https://510kreport.com/company/dreamed-diabetes